KURE KraneShares MSCI All China Health Care Index ETF Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
06:35
Oct 08
Oct 08
Bloomberg Markets
China/HK biotech offers good return prospects
Despite depressed overall sentiment, biotech names in China and Hong Kong have been offering good returns year-to-date and present a favorable return prospect.
KURE
KraneShares MSCI All China Health Care Index ETF
Long
1ST
—
—
05:44
Oct 06
Oct 06
Bloomberg Markets
Washed-out China consumer healthcare rebound
Chinese consumer and healthcare sectors previously traded at very high multiples but have been completely washed out; they are structural stories likely to do well in the expected Q4 broad market rally.
KURE
KraneShares MSCI All China Health Care Index ETF
Long
1ST
—
—
04:55
Sep 30
Sep 30
Bloomberg Markets
China/India healthcare exposure at multi-year high.
Exposure to healthcare in China and India is at the highest level in 3-4 years due to improvement in the global CDMO cycle, Chinese companies' advanced technology and low cost structure, and attractive specialty pharma/biotech opportunities including GLP-1 and cancer drugs.
KURE
KraneShares MSCI All China Health Care Index ETF
Long
1ST
—
—
About KURE Investor Commentary
Across the available history and selected sources, Buzzberg tracks KURE (KraneShares MSCI All China Health Care Index ETF) across 5 sources: 19 bullish vs 0 bearish calls from 20 authors. Historical directional balance: 79% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 24 total trade ideas tracked. Past 7 days, before deduplication: 1 other directions. Latest voices: Hao Hong, Yan Wang, Vivian Lin Thurston.